Previous Years' Career Support Funds Granted

2016 Career Support Grants

Administering Institution	Fellow	Title	Amount (excl. GST)
Garvan Institute of Medical Research	Dr Marina Pajic	Immune modulators and anti-invasive treatments for pancreatic cancer: a new therapeutic partnership	$150,000
Garvan Institute of Medical Research	Dr David Gallego Ortega	The challenge of tumour heterogeneity, harnessing single cell molecular phenotype capacity	$597,118
Cancer Council NSW	Dr Natalie Taylor	Hide and seek with hereditary cancer: Translating evidence into practice to identify colorectal cancer patients with a high risk of Lynch syndrome	$598,251
University of New South Wales	Dr Orazio Vitorio	An anticancer chemically-modified natural compound targeting copper in neuroblastoma	$150,000
University of Newcastle	Dr Lei Jin	Overcoming resistance of metastatic melanoma to treatment with a focus on targeting a novel survival signaling pathway	$150,000
University of Newcastle	Dr Simon Keely	Investigating the role of hypoxia in tumour biology and microbiota interactions using a novel orthotopic model of colorectal cancer	$587,136
$2,382,505

Early Career Fellowships (ECF)

Administering Institution	Fellow	Title	Amount (excl. GST)
Garvan Institute of Medical Research	Dr Angela Chou	Biomarker-driven preclinical trial of of pancreatic cancer defines a CDK4/6 inhibitor responsive molecular subtype	480,000
University of New South Wales	Dr Daniel Carter	Investigating MYCN-driven mitotic deregulation in neuroblastoma	$571,338
University of New South Wales	Dr Pei Yan Liu	Eradication of neuroblastoma by targeting a novel long non-protein-coding RNA	$576,000
University of New South Wales	Dr Dominik Beck	Long non-coding RNA expression improves the risk profiling and treatment outcomes for patients with Acute Myeloid Leukaemia	$549,039
University of New South Wales	Dr Ying Zhu	Rapid isolation and analysis of circulating exosomes using label-free nanoplasmonic sensors for non-invasive breast cancer diagnostics	$572,268
University of Newcastle	Dr Matthew Dun	Targeting activated signalling and oxidative stress pathways in acute myeloid leukaemia	$150,000
University of Sydney	Dr Chun-Chien Shieh	Real-time In-vivo Imaging during Lung Cancer Radiotherapy	$389,686
University of Sydney	Dr Emily Colvin	Evaluation of lysyl oxidase inhibitors as a new treatment for ovarian cancer	$150,000
University of Sydney	Dr Holly Bolton	Improving leukaemia therapy through prevention of graft-versus-host disease	$576,000
University of Sydney	Dr Megan Best	Overcoming psychosocial and ethical issues in cancer genomics: Translating test results into behavioural change	$564,666
University of Sydney	Dr Kristina Cook	Losing Sleep Over Cancer: Regulation of HIF-1 in Sleep Apnoea and Tumour Development	$597,219
University of Sydney	Miss Maiken Lise Marcker Espersen	Clinical proteomics and personalised treatment in ovarian cancer	$416,665
$5,592,881

2015 Career Support Grants

Future Research Leader Fellowships


The Cancer Institute NSW Future Research Leader Fellowships are aimed at encouraging high calibre interstate and international emerging researchers to establish a substantial program of research at a NSW institution.

ID	Recipient	Project Title	Administering Institution	Translational Cancer Research Centre/Unit	Funded
2015/FRL101	Dr Mark Polizzotto	Immune modulatory agents in people with HIV and cancer: prevention, treatment, and implications for HIV eradication	The University of New South Wales	Translational Cancer Research Network	$796,305
2015/FRL106	Dr Mark Larance	Nutrient Deprivation and the Protective Proteome for the Prevention of Disease	The University of Sydney	Sydney Catalyst	$1,000,000
$1,796,305

Recipient

Project Title

Administering Institution

Translational Cancer Research Centre/Unit

Funded

2015/FRL101

Dr Mark Polizzotto

Immune modulatory agents in people with HIV and cancer: prevention, treatment, and implications for HIV eradication

The University of New South Wales

Translational Cancer Research Network

$796,305

2015/FRL106

Dr Mark Larance

Nutrient Deprivation and the Protective Proteome for the Prevention of Disease

The University of Sydney

Sydney Catalyst

$1,000,000

$1,796,305

Career Development Fellowships

ID	Recipient	Project Title	Administering Institution	Funded
2015/CDF102	Dr Joshua McCarroll	Nanomedicine-based treatment to inhibit lung cancer growth and metastases	The University of New South Wales	$150,000
2015/CDF107	Dr Lenka Munoz	Dual targeting of EGFR for efficacious glioblastoma therapy	University of Sydney	$592,791
2015/CDF108	Dr Loretta Lau	Towards a therapy for aggressive cancers that lack a telomere maintenance mechanism	Sydney Children’s Hospitals Network (Randwick & Westmead) inc. The Royal Alexandra Hospital for Children	$600,000
2015/CDF110	A/Professor David Smith	Fifteen year quality of life, survivorship and survival outcomes for prostate cancer: The NSW Prostate Cancer Care and Outcomes Study (PCOS-15)	Cancer Council NSW	$569,128
2015/CDF111	Dr Nadeem Omar Kaakoush	The role of microbes in inflammation and metaplasia within the oesophageal adenocarcinoma cascade	The University of New South Wales	$593,269
2015/CDF114	Associate Professor Anne Cust	Epidemiological and intervention translational research to improve melanoma prevention and survivorship outcomes	University of Sydney	$87,500
$2,592,688

Early Career Fellowships

2015/ECF102	Dr Duohui Jing	Reversing glucocorticoid resistance in paediatric acute lymphoblastic leukaemia – a novel epigenetic mechanism linked to basic DNA structure	The University of New South Wales	$606,479
2015/ECF108	Dr Angelica Marie Merlot	Pharmacological Targeting Approach for Novel Anti-Cancer Chemotherapeutics Implementing Innovative Albumin-Based Nanoparticles	University of Sydney	$450,000
2015/ECF111	Dr Phillip Fromm	Therapeutic Vaccination for Prostate Cancer using mRNA Loaded Blood Dendritic Cells	Anzac Research Institute	$566,445
2015/ECF113	Dr Ben Roediger	Single cell analysis as a diagnostic and prognostic approach in systemic mastocytosis	University of Sydney	$600,000
2015/ECF117	Dr Elizabeth Hinde	Nuclear delivery of DNA chemotherapeutics by pathogen shaped nanoparticles	The University of New South Wales	$416,690
2015/ECF138	Dr Seong Beom (Charlie) Ahn	Next Generation Colorectal Cancer Biomakers and Treatment	Macquarie University	$574,266
2015/ECF144	Dr Flora Tzelepis	A randomised controlled trial of the effectiveness of real-time video counselling on smoking cessation in smokers residing in regional and remote areas	University of Newcastle	$592,843
2015/ECF152	Dr Gillian Gould	Improving strategies for the management of smoking cessation in NSW pregnant Aboriginal women: the Indigenous Counselling and Nicotine (ICAN) QUIT in Pregnancy Trial	University of Newcastle	$450,000
2015/ECF157	Dr James Wilmott	Identifying novel therapeutic targets for the treatment of melanoma in adolescents and young adults	University of Sydney	$429,481
$5,128,340

2014 Career Support Grants

Early Career Fellowships

14/ECF/1–02	Dr Alexander Menzies	University of Sydney	Identifying predictive biomarkers of current systemic therapies and the discovery of new targets and future treatments to improve survival in metastatic melanoma.	$360,000
14/ECF/1–06	Dr Michael Marinovich	University of Sydney	Evidence translation in breast cancer surgical planning	$324,000
14/ECF/1–11	Dr Ursula Sansom-Daly	University of New South Wales	Novel approaches to address barriers to care among adolescents and young adults with cancer: Intervention research targeting vulnerable populations.	$179,796
14/ECF/1–12	Dr Wing Hin Lee	University of Sydney	Inhalable paclitaxel loaded-iron oxide nanoparticle for lung cancer therapy	$592,183
14/ECF/1–23	Dr Ruth Pidsley	Garvan Institute of Medical Research	The next-generation in prostate cancer biomarkers: using epigenetics to distinguish high-risk from low-risk disease	$597,651
14/ECF/1–46	Dr Ryan Courtney	University of New South Wales	Reducing tobacco smoking among low-ses smokers: A RCT to improve compliance with treatment, smoking cessation and health economic outcomes	$558,512
14/ECF/1–57	Dr Andrew Hutchinson	University of Technology, Sydney	Preclinical assessment of phosphatidylserine targeting monoclonal antibodies in multiple myeloma.	$590,500

Career Development Fellowships

ID	Recipient	Project Title	Administering Institution	Funded
14/CDF/1–16	Dr Jiang Chen	University of Newcastle	Overcoming Resistance of Metastatic Melanoma to treatment: MicroRNA-dependent expression of INPP4B as a biomarker and therapeutic target in melanoma	$598,176
14/CDF/1–17	Dr Nikola Bowden	University of Newcastle	Investigation of the DNA repair protein XPC in melanoma treatment resistance.	$600,000
14/CDF/1–21	Dr Pradeep Tanwar	University of Newcastle	Targeting chemoresistant ovarian cancer cells	$508,396
14/CDF/1–25	Associate Professor Karen Canfell	University of New South Wales	Health economic evaluation of new approaches to screening for cancers of the cervix, prostate, colorectum and lung.	$594,000

2013 Career Support Grants

Early Career Fellowships 13/ECF/1–01

13/ECF/1–01	Dr Orazio Vittorio	Dextran-Catechin conjugation with SPIONs: a potential targeted therapy against gliobastoma multiforme.	University of New South Wales	$600,000
13/ECF/1–02	Dr Morten Thaysen Andersen	The functional role of human CD147 N-glycosylation in cancer development using a hepatocellular carcinoma model system.	Macquarie University	$599,391
13/ECF/1–03	Dr Vanessa Sequeira	Targeting melanoma with a novel class of anti-actin compounds.	University of New South Wales	$600,000
13/ECF/1–04	Dr Andreia Pinho	Unravelling the role of the Slit/Robo signalling pathway in pancreatic tumourigenesis.	Garvan Institute of Medical Research	$597,462
13/ECF/1–07	Dr Maarit Laaksonen	The burden of cancer - prevention, treatments, and costs.	University of New South Wales	$396,175
13/ECF/1–08	Dr George Sharbeen	Base Excision Repair as a Therapeutic Target in Pancreatic Cancer.	University of New South Wales	$600,000
13/ECF/1–09	Dr Lindsay Wu	Calorie restriction mimetics for the treatment of hepatocellular carcinoma.	University of New South Wales	$594,451
13/ECF/1–10	Dr Anne Sugetha Vanniasinghe	Targeting mitochondria and lipid metabolism as novel therapeutic approach in Diffuse Intrinsic Pontine Glioma.	University of New South Wales	$427,816
13/ECF/1–11	Dr Megan Passey	Reducing tobacco harm among groups with high smoking prevalence.	University of Sydney	$597,824
13/ECF/1–13	Dr Justin Wong	Linking mutations and epigenetic silencing of splicing factors to aberrant splicing in acute myeloid leukaemia.	University of Sydney	$600,000
13/ECF/1–15	Dr John Kipritidis	On-line ventilation imaging to reduce toxicity in lung cancer radiotherapy.	University of Sydney	$552,883
13/ECF/1–16	Dr Sarah Hayes	Identification of predictive biomarkers of treatment response in Non-Small Cell Lung Cancer patients.	University of Sydney	$599,347
13/ECF/1–17	Dr Kimberley Kaufman	Mechanisms of tumourrecurrence and chemotherapy escape in glioblastoma multiforme.	University of Sydney	$535,000
13/ECF/1–25	Dr Maté Biro	Mechanobiology of cellular protrusions and the actomyosin cortex in invasive tumour cell migration.	University of Sydney	$600,000
13/ECF/1–33	Dr Lei Jin	RIPK1 as a novel therapeutic target in melanoma.	University of Newcastle	$592,459
13/ECF/1–34	Dr Matthew Dun	Identifying novel therapeutic targets for the treatment of Acute Myeloid Leukaemia.	University of Newcastle	$600,000
13/ECF/1–37	Dr Allison Boyes	Supportive care in the digital age: Harnessing new technologies to improve adjustment to haematological cancer.	University of Newcastle	$501,553
13/ECF/1–39	Dr Kimberley Beaumont	Rab27a as a novel therapeutic target: Investigating the role of Rab27a in melanoma growth and invasion.	University of Sydney	$568,974
13/ECF/1–45	Dr Brian Gloss	Short-phase transcriptional programs in mammalian development influence cancer biology.	Garvan Institute of Medical Research	$584,458
13/ECF/1–46	Dr Mark Cowley	Tumour evolution, and early detection of breast cancer empowered by massively parallel sequencing and in vivo imaging	Garvan Institute of Medical Research	$600,000

Career Development Fellowships 13/CDF/1–01

13/CDF/1–01	Dr Marina Pajic	From functional genomics to precision medicine: The therapeutic potential of targeting ROCK signalling in pancreatic cancer.	Garvan Institute of Medical Research	$150,000
13/CDF/1–03	Dr Goli Samimi	Development of a Blood-Based DNA Methylation Assay for Detection of High Grade Serous Ovarian Cancer in High Risk Women.	Garvan Institute of Medical Research	$600,000
13/CDF/1–05	Dr Catherine Caldon	Synergy between proliferation defects and DNA damage in cancer.	Garvan Institute of Medical Research	$449,532
13/CDF/1–09	Dr Yu Zheng	Characterization and Functional Analysis of the Vitamin D Receptor Isoforms and their Role in Breast Cancer Progression: Experimental and Human Translational Studies.	ANZAC Research Institute	$594,000

Future Research Leader Fellowships 13/FRL/1–02

Future Research Leader Fellowships
The Cancer Institute NSW Future Research Leader Fellowships are aimed at encouraging high calibre interstate and international emerging researchers to establish a substantial program of research at a NSW institution.
ID	Recipient	Project Title	Administering Institution	Funded
13/FRL/1–02	Dr David Croucher	Mapping and manipulating therapeutically induced JNK network architecture to tackle breast cancer chemoresistance.	Garvan Institute of Medical Research	$1,157,608
13/FRL/1–03	Dr Tara Roberts	Understanding the role of SMG1 as a tumour suppressor.	University of Western Sydney	$1,225,257

Early Career Fellowships 12/ECF/2–15

ID	Recipient	Project Title	Administering Institution	Funded
12/ECF/2–15	Dr Peter Kelly	Cancer prevention in marginalised populations: a randomised controlled trial of a multiple risk factor reduction program.	University of Wollongong	$594,110
12/ECF/2–17	Dr Zaklina Kovacevic	Targeting the metastasissuppressor NDRG1 for the treatment of pancreatic cancer	University of Sydney	$455,394
12/ECF/2–33	Dr Phillippa Taberlay	De-looping DNA loops using epigenetic cancer therapies	Garvan Institute of Medical Research	$582,876
12/ECF/2–08	Dr Katie Dixon	Novel vitamin D-like compounds to reduce DNA and other molecular damage after UV radiation	University of Sydney	$600,000
12/ECF/2–04	Dr Emily Colvin	Characterising the tumour microenvironment of epithelial ovarian cancer	University of Sydney	$599,215
12/ECF/2–34	Dr Bente Talseth-Palmer	Identification of genetic factors of inherited colon cancer	University of Newcastle	$599,798

Career Development Fellowships 12/CDF/2–26

ID	Recipient	Project Title	Administering Institution	Funded
12/CDF/2–26	Dr Hilda Pickett	Molecular mechanisms of telomere length control	Children's Medical Research Institute	$599,110
12/CDF/2–28	Dr William Ritchie	Small non-coding RNAs control alternative splicing in Chronic Myeloid Leukaemia	University of Sydney	$600,000
12/CDF/2–25	A/Prof Sallie-Anne Pearson	Post-market surveillance of cancer medicines: Generating evidence for clinical and policy practice using linked health administrative data	University of Sydney	$150,000
12/CDF/2–03	Dr Linda Bendall	Microenvironmental Impact in the Treatment of Acute Lymphoblastic Leukaemia	University of Sydney	$150,000
12/CDF/2–13	Dr Jeremy Henson	Using the CC DNA biomarker to investigate the regulation of ALT, develop a blood test for ALT+ cancer activity and develop ALT targeted cancer therapies	Children's Medical Research Institute	$150,000
12/CDF/2–23	Dr Umaimintha Palendira	Mechanisms that control oncogenic Epstein Barr virus infection and their dysregulation in immunodeficiency	Garvan Institute of Medical Research	$598,533

Future Research Leader Fellowships 11/FRL/3–02

The Cancer Institute NSW Future Research Leader Fellowships are aimed at encouraging high calibre interstate and international emerging researchers to establish a substantial program of research at a NSW institution.
ID	Recipient	Project Title	Administering Institution	Funded
11/FRL/3–02	Dr James Rae	Genetic Predictors of Anti-Estrogen Clinical Activity in Breast Cancer Patients.	Garvan Institute of Medical Research	$1,250,000
11/FRL/3–03	Dr Eric Collisson	Integrative Modeling and Targeting of Genomic Anomalies in Pancreatic Ductal Adenocarcinoma.	Garvan Institute of Medical Research	$1.249,935
11/FRL/5–02	Dr Anthony Cesare	Targeting TRF2 function to prevent cancer cell growth.	Children's Medical Research Institute	$1,218,795

Career Development Fellowships 11/CDF/3–05

ID	Recipient	Project Title	Administering Institution	Funded
11/CDF/3–05	A/Prof Tracy Bryan	Structural and functional analyses of telomerase, a major anti-cancer target	Children's Medical Research Institute	$300,000
11/CDF/3–25	Dr Tim Molloy	Micro-RNA regulation or radiotherapy resistance in cancer	Garvan Institute of Medical Research	$597,984
11/CDF/3–26	Prof Elizabeth Musgrove	Using functional genomics in breast and pancreatic cancer to define and refine targeted therapies and identify potential cell cycle regulatory oncogenes	Garvan Institute of Medical Research	$150,000
11/CDF/3–38	Dr Jenny Yingzi Wang	Linking Wnt signalling and epigenetic regulation of tumour suppressors - developing novel epigenetic therapies against AML	University of New South Wales	$600,000
11/CDF/3–39	Prof Wolfgang Weninger	Real time visualisation of tumor associated-antigen specific T cell behaviour in vivo	University of Sydney	$600,000
$2,247,984

Early Career Development Fellowships 11/ECF/3–01

ID	Recipient	Project Title	Administering Institution	Funded
11/ECF/3–to01	Dr David Chang	Novel Biomarker Guided Therapeutic Strategies for Pancreatic Cancer	Garvan Institute of Medical Research	$365.491
11/ECF/3–to18	Dr Elizabeth Iorns	Identifying and characterizing genes that regulate breast tumorigenesis	Garvan Institute of Medical Research	$600,000
11/ECF/3–to43	Dr Claire E Wakefield	Prevention and management of psychological distress in families affected by paediatric cancer	University of New South Wales	$577,535
$1,543,026

NSW Cancer Plan:
G2
O6

Tags: Fellowships grant